How much funding has Neurent Medical raised?

Neurent Medical has raised $135.0M in total funding, most recently a Series C round.

Who are Neurent Medical's investors?

Neurent Medical's investors include EQT AB, Fountain Healthcare Partners, MVM Partners, Sofinnova Partners, Atlantic Bridge, Claret Capital Partners.

Where is Neurent Medical headquartered?

Neurent Medical is headquartered in United States.

What industry is Neurent Medical in?

Neurent Medical operates in Healthcare.

How many employees does Neurent Medical have?

Neurent Medical has 11-50 employees.

Neurent Medical

Experience the Difference

United States · $135.0M raised

Healthcare

Employees: 11–50
Business Model: B2B
Website: neuromark.com

Total Funding: $135.0M
Last Round: $74.0M Series CFeb 2026
Rounds: 4

About

Neurent Medical is a medical device company developing the NEUROMARK System, a minimally invasive radiofrequency ablation device for treating chronic rhinitis (CR) by targeting overactive posterior nasal nerves. The NEUROMARK System uses low-power energy to disrupt these nerves, providing durable relief from CR symptoms including runny nose, congestion, and postnasal drip, with 91% of clinical trial participants achieving clinically meaningful improvement at one year. The company's mission is to offer ENT providers a precise, safe, and clinically proven treatment that addresses the root cause of CR rather than just managing symptoms.

Summary

Neurent Medical is a Healthcare company based in United States. It has raised $135.0M in total across 4 rounds, most recently a $74.0M Series C round in Feb 2026. Investors include EQT AB, Fountain Healthcare Partners and MVM Partners.